AI-enabled pathology has arrived, enabling accelerated discovery, improved lab economics and efficiency, and the advancement of personalized care. Proscia’s computational pathology solutions help today’s labs overcome some of their biggest challenges in research and diagnosis. And no matter where your AI-based solution was developed, our Concentriq® digital pathology platform integrates it directly into your routine workflow.
Platform + AI
The Concentriq digital pathology platform integrates AI directly into the routine workflow. You can launch AI applications from Concentriq to power computational pathology at your organization.
Dermatopathology:
Proscia DermAI*
DermAI automatically classifies every dermatopathology slide, leveraging a highly accurate algorithm-based on more than 13,000 images—to streamline your high-volume dermatopathology workflow.
DermAI highlights the promise of AI to deliver value in routine practice by:
- Helping pathologists prioritize their worklists
- Ensuring that cases are most efficiently routed to the right pathologist
- Providing a second read on every case for extra confidence
Read more about Proscia’s breakthrough dermatopathology research
*For Research Use Only in the United States: requires FDA clearance.
Biomarker Quantification:
Visiopharm VIS AI-Image Analysis Suite
Visiopharm® is a world leader in AI-driven digital precision pathology software, and their AI-based image analysis and tissue mining tools support research and drug development worldwide. With the most advanced and sophisticated artificial intelligence, they deliver tissue data mining tools, precision results, and workflows.
With seamless bidirectional integration between Visiopharm’s VIS AI-image analysis suite and the Concentriq® digital pathology platform from Proscia, you can stream images and annotations directly from Concentriq into Visiopharm, build and run analyses using Visiopharm’s suite of tools and algorithms, and send results back to Concentriq with just one click.
Prostate:
Ibex Galen™ Prostate Solution*
Proscia and Ibex have joined forces to deliver a unified software solution that powers AI-enabled workflows for prostate cancer diagnosis, helping laboratories drive meaningful productivity and quality gains.
*For Research Use Only in the United States: requires FDA clearance.
Join us to accelerate the future of computational pathology
Interested in partnering with us to validate new AI technology, or have an app you would like to integrate with Concentriq?